Safety and dose modification for patients receiving niraparib von Berek, J.S., Matulonis, U.A., Peen, U., Ghatage, P., Mahner, S., Redondo, A., Lesoin, A., Colombo, N., Vergote, I., Rosengarten, O., Ledermann, J., Pineda, M., Ellard, S., Sehouli, J., Gonzalez-Martin, A., Berton-Rigaud, D., Madry, R., Reinthaller, A., Hazard, S., Guo, W., Mirza, M.R.

Volltext

Monkeypox: second human case observed in Ivory Coast (rural health sector of Daloa von Merouze, F, Lesoin, J J

Volltext

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer von Mirza, Mansoor R, Monk, Bradley J, Herrstedt, Jørn, Oza, Amit M, Mahner, Sven, Redondo, Andrés, Fabbro, Michel, Ledermann, Jonathan A, Lorusso, Domenica, Vergote, Ignace, Ben-Baruch, Noa E, Marth, Christian, Mądry, Radosław, Christensen, René D, Berek, Jonathan S, Dørum, Anne, Tinker, Anna V, du Bois, Andreas, González-Martín, Antonio, Follana, Philippe, Benigno, Benedict, Rosenberg, Per, Gilbert, Lucy, Rimel, Bobbie J, Buscema, Joseph, Balser, John P, Agarwal, Shefali, Matulonis, Ursula A

Volltext

Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study von Joly, F., Ahmed-Lecheheb, D., Kalbacher, E., Heutte, N., Clarisse, B., Grellard, J.M., Gernier, F., Berton-Rigaud, D., Tredan, O., Fabbro, M., Savoye, A.M., Kurtz, J.E., Alexandre, J., Follana, P., Delecroix, V., Dohollou, N., Roemer-Becuwe, C., De Rauglaudre, G., Lortholary, A., Prulhiere, K., Lesoin, A., Zannetti, A., N’Guyen, S., Trager-Maury, S., Chauvenet, L., Abadie Lacourtoisie, S., Gompel, A., Lhommé, C., Floquet, A., Pautier, P.

Volltext

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial von Del Campo, Josep M, Matulonis, Ursula A, Malander, Susanne, Provencher, Diane, Mahner, Sven, Follana, Philippe, Waters, Justin, Berek, Jonathan S, Woie, Kathrine, Oza, Amit M, Canzler, Ulrich, Gil-Martin, Marta, Lesoin, Anne, Monk, Bradley J, Lund, Bente, Gilbert, Lucy, Wenham, Robert M, Benigno, Benedict, Arora, Sujata, Hazard, Sebastien J, Mirza, Mansoor R

Volltext

Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Mea... von Friedlander, M., Rau, J., Lee, C.K., Meier, W., Lesoin, A., Kim, J.-W., Poveda, A., Buck, M., Scambia, G., Shimada, M., Hilpert, F., King, M.T., Debruyne, P., Bologna, A., Malander, S., Monk, B.J., Petru, E., Calvert, P., Herzog, T.J., Barrett, C., du Bois, A.

Volltext

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial von Kurtz, Jean-Emmanuel, Pujade-Lauraine, Eric, Oaknin, Ana, Belin, Lisa, Leitner, Katharina, Cibula, David, Denys, Hannelore, Rosengarten, Ora, Rodrigues, Manuel, de Gregorio, Nikolaus, Martinez García, Jeronimo, Petru, Edgar, Kocián, Roman, Vergote, Ignace, Pautier, Patricia, Schmalfeldt, Barbara, Gaba, Lydia, Polterauer, Stephan, Mouret Reynier, Marie-Ange, Sehouli, Jalid, Churruca, Cristina, Selle, Frédéric, Joly, Florence, D'Hondt, Véronique, Bultot-Boissier, Émilie, Lebreton, Coriolan, Lotz, Jean-Pierre, Largillier, Rémy, Heudel, Pierre-Etienne, Heitz, Florian

Volltext

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group von Heudel, P-E, Fabbro, M, Roemer-Becuwe, C, Kaminsky, M C, Arnaud, A, Joly, F, Roche-Forestier, S, Meunier, J, Foa, C, You, B, Priou, F, Tazi, Y, Floquet, A, Selle, F, Berton-Rigaud, D, Lesoin, A, Kalbacher, E, Lortholary, A, Favier, L, Treilleux, I, Ray-Coquard, I

Volltext

Alienor/ENGOT-ov7 randomized trial exploring weekly paclitaxel (wP) + bevacizumab (bev) vs wP alone for patients with ovarian sex cord tumors (SCT) in relapse von Ray-Coquard, I.L., Harter, P., Lorusso, D., Dalban, C., Vergote, I.B., Fujiwara, K., Gladieff, L., Lueck, H.-J., Floquet, A., Lesoin, A.F., Schnelzer, A., Pignata, S., Selle, F., Sehouli, J., Brocard, F., Mangili, G., Pautier, P., De Giorgi, U., Provansal, M., Heudel, P.-E.

Volltext

Incorporation of pazopanib in maintenance therapy of ovarian cancer von du Bois, Andreas, Floquet, Anne, Kim, Jae-Weon, Rau, Joern, del Campo, Josep M, Friedlander, Michael, Pignata, Sandro, Fujiwara, Keiichi, Vergote, Ignace, Colombo, Nicoletta, Mirza, Mansoor R, Monk, Bradley J, Kimmig, Rainer, Ray-Coquard, Isabelle, Zang, Rongyu, Diaz-Padilla, Ivan, Baumann, Klaus H, Mouret-Reynier, Marie-Ange, Kim, Jae-Hoon, Kurzeder, Christian, Lesoin, Anne, Vasey, Paul, Marth, Christian, Canzler, Ulrich, Scambia, Giovanni, Shimada, Muneaki, Calvert, Paula, Pujade-Lauraine, Eric, Kim, Byoung-Gie, Herzog, Thomas J, Mitrica, Ionel, Schade-Brittinger, Carmen, Wang, Qiong, Crescenzo, Rocco, Harter, Philipp

Volltext

Bcl-2 proteins expression and response to navitoclax in platinum resistant/refractory recurrent ovarian cancer (PROC) von Brachet, P.E., Joly Lobbedez, F., Fabbro, M., Leary, A., Medioni, J., Follana, P., Lesoin, A.F., Frenel, J.-S., Abadie Lacourtoisie, S., Floquet, A., Gladieff, L., You, B., Gavoille, C., Kalbacher, E., Briand, M., Just, P.A., Blanc-Fournier, C., Giffard, F., Clarisse, B., Poulain, L.

Volltext

Safety and dose modification for patients receiving niraparib von Berek, J S, Matulonis, U A, Peen, U, Ghatage, P, Mahner, S, Redondo, A, Lesoin, A, Colombo, N, Vergote, I, Rosengarten, O, Ledermann, J, Pineda, M, Ellard, S, Sehouli, J, Gonzalez-Martin, A, Berton-Rigaud, D, Madry, R, Reinthaller, A, Hazard, S, Guo, W, Mirza, M R

Volltext

The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG... von Lenck, C., Chopin, N., Gouy, S., Bonsang-Kitzis, H., Martinez-Gomez, C., Radosevic-Robin, N., Martin, S., Lefeuvre-plesse, C., Lambaudie, E., Leblanc, E., Guyon, F., Classe, J.-M., Ramanah, R., Beurrier, F., Angeles, M.A., Pomel, C., Joly, F., de la Motte Rouge, T., Provansal, M., Lesoin, A., Floquet, A., Berton, D., Kalbacher, E., Chakiba, C., Meeus, P., Selle, F., Treilleux, I., Lecuru, F., Pautier, P., Ray-Coquard, I.

Volltext

Correction to: “Safety and dose modification for patients receiving niraparib” von Berek, J.S., Matulonis, U.A., Peen, U., Ghatage, P., Mahner, S., Redondo, A., Lesoin, A., Colombo, N., Vergote, I., Rosengarten, O., Ledermann, J., Pineda, M., Ellard, S., Sehouli, J., Gonzalez-Martin, A., Berton-Rigaud, D., Madry, R., Reinthaller, A., Hazard, S., Guo, W., Mirza, M.R.

Volltext

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer von Ray‐Coquard, Isabelle, Cibula, David, Mirza, Mansoor R., Reuss, Alexander, Ricci, Caterina, Colombo, Nicoletta, Koch, Horst, Goffin, Frédéric, González‐Martin, Antonio, Ottevanger, Petronella B., Baumann, Klaus, Bjørge, Line, Lesoin, Anne, Burges, Alexander, Rosenberg, Per, Gropp‐Meier, Martina, Harrela, Maija, Harter, Philipp, Frenel, Jean‐Sébastien, Minarik, Tomas, Pisano, Carmela, Hasenburg, Annette, Merger, Michael, Bois, Andreas

Volltext

Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type von Pautier, P., Ribrag, V., Duvillard, P., Rey, A., Elghissassi, I., Sillet-Bach, I., Kerbrat, P., Mayer, F., Lesoin, A., Brun, B., Crouet, H., Barats, J.C., Morice, P., Lhommé, C.

Volltext

The French national network dedicated to rare gynecological cancers diagnosis andmanagement could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG... von Lenck, C., Chopin, N., Gouy, S., Bonsang-Kitzis, H., Martinez-Gomez, C., Radosevic-Robin, N., Martin, S., Lefeuvre-plesse, C., Lambaudie, E., Leblanc, E., Guyon, F., Classe, J-M, Ramanah, R., Beurrier, F., Angeles, M. A., Pomel, C., Joly, F., Rouge, T. de la Motte, Provansal, M., Lesoin, A., Floquet, A., Berton, D., Kalbacher, E., Chakiba, C., Meeus, P., Selle, F., Treilleux, Lecuru, F., Pautier, P., Ray-Coquard

Volltext

2772 Circulating tumor cells kinetics in ovarian carcinoma: correlation with baseline characteristics and CA-125 levels in the randomized ANTHALYA trial evaluating bevacizumab in t... von Cottu, P, Rouge, T. De La Motte, Pautier, P, Provansal, M, Floquet, A, Selle, F, Mouret-Reynier, M.A, Fabbro, M, Kalbacher, E, Piprot, C, Follana, P, Lesoin, A, Medioni, J, Menguy, V, Ghazi, Y, Bidard, F.C, Dubot, C, Joly, F

Volltext

Circulating tumor cells as prognostic marker in ovarian carcinoma: Results from the ANTHALYA study von de La Motte Rouge, T., Cottu, P., Pautier, P., Provansal, M., Floquet, A., Selle, F., Fabbro, M., Kalbacher, E., Follana, P., Lesoin, A.F., Medioni, J., Dupin, J., Ferri, R-M., Bidard, F-C., Dubot, C., Rouzier, R., Joly Lobbedez, F.

Volltext

972PBcl-2 proteins expression and response to navitoclax in platinum resistant/refractory recurrent ovarian cancer (PROC) von Brachet, P E, Joly Lobbedez, F, Fabbro, M, Leary, A, Medioni, J, Follana, P, Lesoin, A F, Frenel, J-S, Abadie Lacourtoisie, S, Floquet, A, Gladieff, L, You, B, Gavoille, C, Kalbacher, E, Briand, M, Just, P A, Blanc-Fournier, C, Giffard, F, Clarisse, B, Poulain, L

Volltext